Interferon-β-1a for the Treatment of Steroid-Refractory Ulcerative Colitis: A Randomized, Double-Blind, Placebo-Controlled Trial Eugen Musch, Tilo Andus, Wolfgang Kruis, Andreas Raedler, Martina Spehlmann, Stefan Schreiber, Bernd Krakamp, Mouhamad Malek, Helmut Malchow, Filip Zavada, Gerhard Engelberg Feurle Clinical Gastroenterology and Hepatology Volume 3, Issue 6, Pages 581-586 (June 2005) DOI: 10.1016/S1542-3565(05)00208-9 Copyright © 2005 American Gastroenterological Association Terms and Conditions
Figure 1 Flow chart of patients included and analyzed. Clinical Gastroenterology and Hepatology 2005 3, 581-586DOI: (10.1016/S1542-3565(05)00208-9) Copyright © 2005 American Gastroenterological Association Terms and Conditions
Figure 2 Median values of CAI from baseline to week 8 for the different treatment groups. Clinical Gastroenterology and Hepatology 2005 3, 581-586DOI: (10.1016/S1542-3565(05)00208-9) Copyright © 2005 American Gastroenterological Association Terms and Conditions